Literature DB >> 15839919

Prognostic significance of insulin-like growth factor (IGF) binding protein-2 to IGF-binding protein-3 ratio in patients undergoing radical cystectomy for invasive transitional cell carcinoma of the bladder.

Hideaki Miyake1, Isao Hara, Kazuki Yamanaka, Mototsugu Muramaki, Hiroshi Eto.   

Abstract

OBJECTIVES: To analyse the prognostic significance of insulin-like growth factor binding protein-2 (IGFBP-2) and IGFBP-3 in patients having a radical cystectomy for invasive bladder cancer. PATIENTS AND METHODS: Tissue samples of invasive bladder cancer were obtained from 97 patients who had radical cystectomy. The expression of IGFBP-2 and IGFBP-3 mRNAs in these samples was measured by real-time reverse transcription-polymerase chain reaction (RT-PCR), and the findings analysed in relation to clinicopathological factors.
RESULTS: During the observation period, 31 patients (group A) developed disease recurrence, while the remaining 66 (group B) had no evidence of recurrence. The expression level of IGFBP-2 mRNA was significantly higher in group A than in B, while IGFBP-3 mRNA expression was significantly lower in group A than in B, and there was a significant difference in the relative expression ratio of IGFBP-2 to IGFBP-3 (BP-2/BP-3 ratio) between the groups. Recurrence-free survival in patients with an elevated BP-2/BP-3 ratio was significantly lower than in those with a normal ratio. Multivariate analysis indicated that an elevated BP-2/BP-3 ratio, but not IGFBP-2 and IGFBP-3 mRNA levels, was an independent predictor of disease recurrence.
CONCLUSIONS: These findings suggest that the BP-2/BP-3 ratio measured by real-time RT-PCR could be useful for predicting disease recurrence in patients who have had a radical cystectomy for invasive bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15839919     DOI: 10.1111/j.1464-410X.2005.05453.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  5 in total

1.  Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling.

Authors:  Renato V Iozzo; Simone Buraschi; Marco Genua; Shi-Qiong Xu; Charalambos C Solomides; Stephen C Peiper; Leonard G Gomella; Rick C Owens; Andrea Morrione
Journal:  J Biol Chem       Date:  2011-08-12       Impact factor: 5.157

2.  Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.

Authors:  David J Degraff; Adam A Aguiar; Robert A Sikes
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

Review 3.  Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity.

Authors:  Georgios Gakis; Arnulf Stenzl
Journal:  World J Urol       Date:  2013-02-09       Impact factor: 4.226

Review 4.  Prognostic value of IGFBP2 in various cancers: a systematic review and meta-analysis.

Authors:  Biao Zhang; Chao-Qun Hong; Yu-Hao Luo; Lai-Feng Wei; Yun Luo; Yu-Hui Peng; Yi-Wei Xu
Journal:  Cancer Med       Date:  2022-05-11       Impact factor: 4.711

5.  Prognostic impact of insulin-like growth factor-I and its binding proteins, insulin-like growth factor-I binding protein-2 and -3, on adverse histopathological features and survival outcomes after radical cystectomy.

Authors:  Reza Sari Motlagh; Victor M Schuettfort; Keiichiro Mori; Satoshi Katayama; Pawel Rajwa; Abdulmajeed Aydh; Nico C Grossmann; Ekaterina Laukhtina; Benjamin Pradere; Hadi Mostafai; Fahad Quhal; Mohammad Abufaraj; Richard Lee; Pierre I Karakiewicz; Yair Lotan; Eva Comprate; Marco Moschini; Paolo Gontero; Shahrokh F Shariat
Journal:  Int J Urol       Date:  2022-04-02       Impact factor: 2.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.